Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer) Clinical Trials in Beijing

To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors